Skip to main content
Psychedelic State(s) of America
Subscribe
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Phillyvoice

Published November 12, 2026 · Updated November 13, 2026

Trump administration invests $4.9 million to research psychedelic as PTSD treatment

Read the full story at Phillyvoice

LSD , ecstasy and other psychedelic drugs. That has mostly kept U.S. research into the drug at a standstill. But the psychedelic has showed promise.

Post on X

Share this story

Share on XShare on LinkedInShare on FacebookShare on WhatsAppShare on Signal

Surfaced by 4 Google Alerts

  • LSD
  • Psychedelic press release
  • Psychedelic crime
  • Psychedelics africa